Remifentanil Versus Rocuronium for Optimizing Video Laryngoscopy-assisted Tracheal Intubation

Phase 4

Not yet recruiting

• Conditions: Tracheal Intubation; Video Laryngoscopy; Remifentanil; Rocuronium

• Registration Number: NCT06564857
• Lead Sponsor: Nordsjaellands Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-6-25
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Not yet recruiting
• Sex: All
• Target Recruitment: 2684

Inclusion Criteria

Inclusion Criteria:<br><br> - Adults > 18 years<br><br> - Undergoing general anaesthesia requiring oro-tracheal intubation<br><br>Exclusion Criteria:<br><br> - Neuromuscular disease that may interfere with neuromuscular monitoring<br><br> - Awake intubation<br><br> - Rapid sequence induction<br><br> - Known allergies or contraindications to rocuronium or remifentanil<br><br> - Patients who do not understand Danish or English or are unable to give informed<br> consent.<br><br> - Oral, pharyngeal, and laryngeal surgery<br><br> - Surgical indication for the use of a nerve stimulator

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proportion of participants with one or more intubation or anaesthesia related adverse events;Proportion of participants with failed first-pass intubation

Secondary Outcome Measures

Name	Time	Method
Lengths of stay at the Post-Anaesthesia Care Unit.